Cholongitas E, Senzolo M, Patch D, Kwong K, Nikolopoulou V, Leandro G, Shaw S, Burroughs A K
Liver Transplantation and Hepatobiliary Medicine Unit, Royal Free Hospital, London, UK.
Aliment Pharmacol Ther. 2006 Apr 1;23(7):883-93. doi: 10.1111/j.1365-2036.2006.02842.x.
Prognostic scores in an intensive care unit (ICU) evaluate outcomes, but derive from cohorts containing few cirrhotic patients.
To evaluate 6-week mortality in cirrhotic patients admitted to an ICU, and to compare general and liver-specific prognostic scores.
A total of 312 consecutive cirrhotic patients (65% alcoholic; mean age 49.6 years). Multivariable logistic regression to evaluate admission factors associated with survival. Child-Pugh, Model for End-stage Liver Disease (MELD), Acute Physiology and Chronic Health Evaluation (APACHE) II and Sequential Organ Failure Assessment (SOFA) scores were compared by receiver operating characteristic curves.
Major indication for admission was respiratory failure (35.6%). Median (range) Child-Pugh, APACHE II, MELD and SOFA scores were 11 (5-15), 18 (0-44), 24 (6-40) and 11 (0-21), respectively; 65% (n = 203) died. Survival improved over time (P = 0.005). Multivariate model factors: more organs failing (FOS) (<3 = 49.5%, > or =3 = 90%), higher FiO(2), lactate, urea and bilirubin; resulting in good discrimination [area under receiver operating characteristic curve (AUC) = 0.83], similar to SOFA and MELD (AUC = 0.83 and 0.81, respectively) and superior to APACHE II and Child-Pugh (AUC = 0.78 and 0.72, respectively).
Cirrhotics admitted to ICU with > or =3 failing organ systems have 90% mortality. The Royal Free model discriminated well and contained key variables of organ function. SOFA and MELD were better predictors than APACHE II or Child-Pugh scores.
重症监护病房(ICU)中的预后评分用于评估预后,但这些评分来自肝硬化患者数量较少的队列。
评估入住ICU的肝硬化患者的6周死亡率,并比较通用和肝脏特异性预后评分。
共纳入312例连续的肝硬化患者(65%为酒精性肝硬化;平均年龄49.6岁)。采用多变量逻辑回归评估与生存相关的入院因素。通过受试者工作特征曲线比较Child-Pugh评分、终末期肝病模型(MELD)评分、急性生理与慢性健康状况评估(APACHE)II评分和序贯器官衰竭评估(SOFA)评分。
入院的主要指征是呼吸衰竭(35.6%)。Child-Pugh评分、APACHE II评分、MELD评分和SOFA评分的中位数(范围)分别为11(5-15)、18(0-44)、24(6-40)和11(0-21);65%(n = 203)的患者死亡。生存率随时间改善(P = 0.005)。多变量模型因素:更多器官功能衰竭(FOS)(<3个器官功能衰竭=49.5%,≥3个器官功能衰竭=90%)、更高的吸入氧浓度(FiO₂)、乳酸、尿素和胆红素;具有良好的辨别能力[受试者工作特征曲线下面积(AUC)=0.83],与SOFA评分和MELD评分相似(AUC分别为0.83和0.81),优于APACHE II评分和Child-Pugh评分(AUC分别为0.78和0.72)。
入住ICU且有≥3个器官系统功能衰竭的肝硬化患者死亡率为90%。皇家自由医院模型辨别能力良好,包含器官功能的关键变量。SOFA评分和MELD评分比APACHE II评分或Child-Pugh评分更能准确预测预后。